The issue first came to light last September, when Cardinal Health, Inc. sent a letter to healthcare providers and consumers warning that their Monoject U-100 1 mL Insulin Syringe Luer-Lock with ...

Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe ...

The FDA labeled BD's safety notice as a Class I event. The warning comes amid several actions from the agency on the safety of syringes.

The affected products include the BD Alaris Syringe Module, BD Alaris PCU, and Alaris PCA Module; model numbers: 8110, 8015, and 8120. These products were distributed between June 19, 2004 and ...

They’re all luer-lock tip Monoject syringes, with sizes ranging from one to 60 milliliters. Related. Baxter infusion pumps face another Class I recall, this time for possible false alarms.

In an April 24 letter to Cardinal Health CEO Steve Mason, the FDA said the company changed from manufacturing its monoject Luer-lock tip syringes and monoject enteral feeding syringes to hiring a ...

The affected syringes are Cardinal Health’s Monoject single use Luer lock syringes 1, 6, 12, 20, 35 and 60 milliliters distributed in the summer. Advertisement More In: ...

The FDA has alerted healthcare providers not to use Cardinal Health (CAH) Monoject syringes with syringe pumps and patient-controlled analgesia pumps over compatibility concerns.

The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.